EMEA-002258-PIP01-17
Key facts
| Active substance |
Recombinant human epidermal growth factor
|
| Therapeutic area |
Endocrinology-Gynaecology-Fertility-Metabolism
|
| Decision number |
P/0038/2018
|
| PIP number |
EMEA-002258-PIP01-17
|
| Pharmaceutical form(s) |
Powder and solvent for solution for injection
|
| Condition(s) / indication(s) |
Treatment of diabetic foot ulcer
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Praxis Pharmaceuticals S.A
Tel. +436643564874
E-mail: j.rogan@inphares.net |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|